Abo Bibliothek: Guest
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen
International Journal of Medicinal Mushrooms
Impact-faktor: 1.423 5-jähriger Impact-Faktor: 1.525 SJR: 0.431 SNIP: 0.716 CiteScore™: 2.6

ISSN Druckformat: 1521-9437
ISSN Online: 1940-4344

Volumes:
Volumen 22, 2020 Volumen 21, 2019 Volumen 20, 2018 Volumen 19, 2017 Volumen 18, 2016 Volumen 17, 2015 Volumen 16, 2014 Volumen 15, 2013 Volumen 14, 2012 Volumen 13, 2011 Volumen 12, 2010 Volumen 11, 2009 Volumen 10, 2008 Volumen 9, 2007 Volumen 8, 2006 Volumen 7, 2005 Volumen 6, 2004 Volumen 5, 2003 Volumen 4, 2002 Volumen 3, 2001 Volumen 2, 2000 Volumen 1, 1999

International Journal of Medicinal Mushrooms

DOI: 10.1615/InterJMedicMush.v5.i3.40
16 pages

Submerged Cultured Mycelium Extracts of Higher Basidiomycetes Mushrooms Selectively Inhibit Proliferation and Induce Differentiation of K562 Human Chronic Myelogenous Leukemia Cells

Majed Yassin
Institute of Evolution, University of Haifa, Mount Carmel, Haifa, Israel; Migal, Galilee Technology Center, Kiryat Shmona, Israel; Galilee Institute for Applied Research, Nazareth, Israel
Jamal A. Mahajna
Migal, Galilee Technology Center, Cancer Drug Discovery Program, Kiryat Shmona; Galilee Institute for Applied Research, Nazareth

ABSTRAKT

Human chronic myelogenous leukemia (CML) is a malignancy of pluripotent hematopoietic cells characterized by a distinctive cytogenetic abnormality known as the Philadelphia (Ph) chromosome, which results in the creation of a p210Bcr–Abl fusion protein with increased tyrosine kinase activity. Forty-two species of Higher Basidiomycetes mushrooms were cultivated as pure cultures in submerged conditions, and dry mycelium was used to prepare 168 different crude extracts. The crude extracts were used to evaluate antiproliferative activity against a number of cancer cell lines, including K562 (human chronic myelogenous leukemia cell line), Jurkat (human T lymphoblast cells), HT29 (human colon adenocarcinoma cells), MH3924A (rat Morris hepatoma), and ABAE (adult bovine aortic endothelial cells) using XTT proliferation assay. Forty-four crude extracts with antiproliferative effect against K562 cells were selected, and eight mycelium extracts were K562-selective compared with MH3924A, HT29, ABAE, and Jurkat cells. Growth inhibition against K562 ranged from 51% to 78% compared with solvent-treated samples. Most crude extracts exhibited a complete or partial cytostatic effect against K562 cells. The anti-proliferative effect observed by the selected crude extracts was attributed to the induction of an apoptosis pathway as determined by Apostain ELISA assay and by monitoring PARP cleavage. It is interesting that crude extract MH428 was the most active extract in inducing apoptosis of K562 cells. In addition, expression levels of p210Bcr–Abl were affected by the presence of the selected crude extracts. Our data revealed a significant inhibition of p210Bcr–Abl expression by MH428 extract, a moderate effect by MH17, and minor changes by the other extracts. Furthermore, mycelium crude extracts were active in inducing erythroid differentiation in K562 cells. Crude extracts Meth178, MH17, and MH428 showed significant ability to induce hemoglobin production in K562 cells, as indicative of erythroid differentiation. The results obtained support the potential use of the crude mycelium extracts for the treatment of CML and beta-globin disorders.


Articles with similar content:

Overview of the Biological Activities of a Methanol Extract from Wild Red Belt Conk, Fomitopsis pinicola (Agaricomycetes), Fruiting Bodies from Central Italy
International Journal of Medicinal Mushrooms, Vol.20, 2018, issue 11
Bruno Tirillini, Roberto Venanzoni, Roberto Maria Pellegrino, Roberto Fabiani, Patrizia Rosignoli, Andrea Arcangeli, Giancarlo Bistocchi, Gabriele Cruciani, Andrea Rubini, Paola Angelini
Andrographolide inhibits human umbilical vein endothelial cell invasion and migration by regulating MMP-2 and MMP-9 during angiogenesis
Journal of Environmental Pathology, Toxicology and Oncology, Vol.30, 2011, issue 1
P. Pratheeshkumar, Girija Kuttan
Inhibitory Activity of Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Higher Basidiomycetes) on Transformed Cells by Human Papillomavirus
International Journal of Medicinal Mushrooms, Vol.16, 2014, issue 2
Vicente Madrid-Marina V., Elizur Montiel-Arcos, Ismael Leon-Rivera, Raul N. Ondarza-Vidaurreta, Enrique Garcia-Villa, Victor H. Bermudez-Morales, Eva Hernandez-Marquez, Patricio Gariglio, Ana I. Burgete-Garcfa, Alfredo Lagunas-Martinez
Antioxidant and Cytotoxic Activities of Ethanolic Extracts and Isolated Fractions of Species of the Genus Phellinus Quél. (Aphyllophoromycetideae)
International Journal of Medicinal Mushrooms, Vol.13, 2011, issue 2
Yanfang Liu, Yan Yang, Libin Ye, Jing-Song Zhang, Jinxia Hu, Na Feng, Hui Chen, Qingjiu Tang
Specificity of the Immunomodulating Activity of Sasa veitchii (Japanese Folk Medicine Kumazasa) to Fungal Polysaccharides
International Journal of Medicinal Mushrooms, Vol.17, 2015, issue 5
Masamichi Tsuboi, Kazuo Takeshita, Masato Kanamori, Yoshiyuki Adachi, Noriko N. Miura, Wataru Sato, Naohito Ohno, Ken-ichi Ishibashi